Vera Therapeutics, Inc. (VERA) Operating cash flow 2020–2025
Vera Therapeutics, Inc. (VERA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$241.1MFY2025 · since FY2020: -$34.8M → -$241.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.1M | -79.0% |
| FY2024 | -$134.7M | -46.1% |
| FY2023 | -$92.2M | -36.4% |
| FY2022 | -$67.6M | -185.1% |
| FY2021 | -$23.7M | +31.9% |
| FY2020 | -$34.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice